Informe de mercado de metabolómica por producto (instrumentos de metabolómica, herramientas y servicios de bioinformática de metabolómica), indicación (cáncer, trastornos cardiovasculares, trastornos neurológicos, errores congénitos del metabolismo y otros), aplicación (descubrimiento de fármacos y biomarcadores, toxicología, nutrigenómica, medicina personalizada y Otros), y Región 2024-2032

Informe de mercado de metabolómica por producto (instrumentos de metabolómica, herramientas y servicios de bioinformática de metabolómica), indicación (cáncer, trastornos cardiovasculares, trastornos neurológicos, errores congénitos del metabolismo y otros), aplicación (descubrimiento de fármacos y biomarcadores, toxicología, nutrigenómica, medicina personalizada y Otros), y Región 2024-2032

Report Format: PDF+Excel | Report ID: SR112025A18097

Language of the Report – English

Sin embargo, el informe puede estar disponible en español por un costo adicional.

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Metabolomics Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Product
    6.1    Metabolomics Instruments
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Metabolomics Bioinformatics Tools and Services
        6.2.1 Market Trends
        6.2.2 Market Forecast
7   Market Breakup by Indication
    7.1    Cancer
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Cardiovascular Disorders
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Neurological Disorders
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Inborn Errors of Metabolism
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Others
        7.5.1 Market Trends
        7.5.2 Market Forecast
8   Market Breakup by Application
    8.1    Biomarker and Drug Discovery
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Toxicology
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Nutrigenomics
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Personalized Medicine
        8.4.1 Market Trends
        8.4.2 Market Forecast
    8.5    Others
        8.5.1 Market Trends
        8.5.2 Market Forecast
9   Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10  SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11  Value Chain Analysis
12  Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13  Competitive Landscape
    13.1    Market Structure
    13.2    Key Players
    13.3    Profiles of Key Players
        13.3.1    Agilent Technologies Inc.
           13.3.1.1 Company Overview
           13.3.1.2 Product Portfolio
           13.3.1.3 Financials
           13.3.1.4 SWOT Analysis
        13.3.2    Biocrates Life Sciences AG
           13.3.2.1 Company Overview
           13.3.2.2 Product Portfolio
        13.3.3    Bio-Rad Laboratories Inc.
           13.3.3.1 Company Overview
           13.3.3.2 Product Portfolio
           13.3.3.3 Financials
           13.3.3.4 SWOT Analysis
        13.3.4    Bruker Corporation
           13.3.4.1 Company Overview
           13.3.4.2 Product Portfolio
           13.3.4.3 Financials
        13.3.5    Danaher Corporation
           13.3.5.1 Company Overview
           13.3.5.2 Product Portfolio
           13.3.5.3 Financials
           13.3.5.4 SWOT Analysis
        13.3.6    Human Metabolome Technologies Inc.
           13.3.6.1 Company Overview
           13.3.6.2 Product Portfolio
           13.3.6.3 Financials
        13.3.7    Metabolon Inc.
           13.3.7.1 Company Overview
           13.3.7.2 Product Portfolio
        13.3.8    Shimadzu Corporation
           13.3.8.1 Company Overview
           13.3.8.2 Product Portfolio
           13.3.8.3 Financials
           13.3.8.4 SWOT Analysis
        13.3.9    Thermo Fisher Scientific Inc.
           13.3.9.1 Company Overview
           13.3.9.2 Product Portfolio
           13.3.9.3 Financials
           13.3.9.4 SWOT Analysis
        13.3.10    Waters Corporation
           13.3.10.1 Company Overview
           13.3.10.2 Product Portfolio
           13.3.10.3 Financials
           13.3.10.4 SWOT Analysis

Informe de mercado de metabolómica por producto (instrumentos de metabolómica, herramientas y servicios de bioinformática de metabolómica), indicación (cáncer, trastornos cardiovasculares, trastornos neurológicos, errores congénitos del metabolismo y otros), aplicación (descubrimiento de fármacos y biomarcadores, toxicología, nutrigenómica, medicina personalizada y Otros), y Región 2024-2032
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials